T
Theratechnologies is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies. We currently market prescription products for people with HIV in the United States. Our research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Show more Show less
Investor insights
Funding rounds participated in
$75M sweet spot round size
Investor type
Public Company
Basic info
Industry
Biotechnology Research
Sectors
Biotechnology Research
Date founded
1993
Funding rounds raised
Total raised
$75M
from investors over 1 rounds
T
Theratechnologies Inc. raised $75M on January 2, 2025